Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1

Status

Recruiting 2Active not recruiting 2Terminated 1

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Thoracic 5Tumor-Agnostic 2Gastrointestinal 2

Conditions

Lung Neoplasms 5Smoking Cessation 2Solitary Pulmonary Nodule 1Pulmonary Disease, Chronic Obstructive 1Motor Activity 1Inflammation 1Disease 1Cardiovascular Diseases 1

Interventions

Carboplatin 191pembrolizumab 155Pemetrexed 134Cisplatin 117durvalumab 71Paclitaxel 71osimertinib 67Nivolumab 66Docetaxel 63Specimen Handling 61atezolizumab 57Magnetic Resonance Spectroscopy 50Etoposide 46Gemcitabine 42Radiotherapy 39Radiosurgery 37130-nm albumin-bound paclitaxel 34Drug Therapy 30Cetuximab 28Bevacizumab 27Ipilimumab 25Taxes 23cemiplimab 22tislelizumab 20Platinum 20amivantamab 18Radiation 18Immunoglobulin G 171,2-diaminocyclohexaneplatinum II citrate 17Disulfides 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Hematologic Tests × Thoracic × 90 days × Clear all
NCT07623473 2026-06-03

NIMBLE

Herlev and Gentofte Hospital

Recruiting
1,800 enrolled
Thoracic

Solitary Pulmonary Nodule, Disease, Lung Neoplasms

NCT01687647 2026-05-29

AMORCE-CBP

University Hospital, Caen

Phase 3 Terminated
463 enrolled
Thoracic

Lung Neoplasms

NCT06620835 2026-04-29

OPTALK

Groupe Francais De Pneumo-Cancerologie

Phase 2 Recruiting
45 enrolled
Thoracic

Lung Neoplasms

NCT03654105 2026-03-27

SMILE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Active not recruiting
2,000 enrolled
Thoracic

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation

NCT05766046 2026-03-27

RISP

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase NA Active not recruiting
7,324 enrolled
Thoracic

Cardiovascular Diseases, Lung Neoplasms, Smoking Cessation, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡